KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Long-Term Investments (2016 - 2026)

Pfizer has reported Long-Term Investments over the past 18 years, most recently at $1.6 billion for Q1 2026.

  • Quarterly Long-Term Investments fell 19.27% to $1.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Mar 2026, down 19.27% year-over-year, with the annual reading at $1.6 billion for FY2025, 27.24% down from the prior year.
  • Long-Term Investments was $1.6 billion for Q1 2026 at Pfizer, roughly flat from $1.6 billion in the prior quarter.
  • Over five years, Long-Term Investments peaked at $16.0 billion in Q2 2022 and troughed at $224.0 million in Q2 2025.
  • The 5-year median for Long-Term Investments is $9.8 billion (2022), against an average of $8.0 billion.
  • Year-over-year, Long-Term Investments soared 87.23% in 2022 and then crashed 97.13% in 2025.
  • A 5-year view of Long-Term Investments shows it stood at $10.8 billion in 2022, then skyrocketed by 41.98% to $15.4 billion in 2023, then tumbled by 85.5% to $2.2 billion in 2024, then fell by 27.24% to $1.6 billion in 2025, then increased by 0.31% to $1.6 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Long-Term Investments are $1.6 billion (Q1 2026), $1.6 billion (Q4 2025), and $2.1 billion (Q3 2025).